OCLN and infection: Finally, to assess the involvement of 5-HT2AR in HCV cell entry in vivo, we evaluated the ability of ezetimibe to inhibit infection of a genotype 2a (JC-1) in immune-competent humanized transgenic mice of chronic HCV infection harboring both human CD81 and OCLN genes (C/OTg) (Chen et al., 2014).